Ignite Creation Date:
2024-05-06 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06196255
Status:
RECRUITING
Last Update Posted:
2024-01-09
First Post:
2023-12-25
Brief Title:
Safety and Efficacy of Anti-FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma RR MM
Sponsor:
Xuzhou Medical University
Organization:
Xuzhou Medical University
Organization Data
Organization:
Xuzhou Medical University
Class:
OTHER
Study ID:
XYFY2023-KL216-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xuzhou Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Kai Lin XuMD
Responsible Party Title:
professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Xuzhou Medical University
Old Name:
None
Old Organization:
None